- Home
- PODD vs NTNX Comparison
PODD vs NTNX Comparison
Compare PODD & NTNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- NTNX
- Stock Information
- Founded
- PODD 2000
- NTNX 2009
- Country
- PODD United States
- NTNX United States
- Employees
- PODD N/A
- NTNX N/A
- Industry
- PODD Medical/Dental Instruments
- NTNX Computer Software: Prepackaged Software
- Sector
- PODD Health Care
- NTNX Technology
- Exchange
- PODD Nasdaq
- NTNX Nasdaq
- Market Cap
- PODD 21.5B
- NTNX 20.7B
- IPO Year
- PODD 2007
- NTNX 2016
- Fundamental
- Price
- PODD $303.15
- NTNX $72.76
- Analyst Decision
- PODD Strong Buy
- NTNX Buy
- Analyst Count
- PODD 19
- NTNX 13
- Target Price
- PODD $320.11
- NTNX $89.33
- AVG Volume (30 Days)
- PODD 782.7K
- NTNX 3.2M
- Earning Date
- PODD 08-07-2025
- NTNX 05-28-2025
- Dividend Yield
- PODD N/A
- NTNX N/A
- EPS Growth
- PODD 67.46
- NTNX N/A
- EPS
- PODD 5.55
- NTNX 0.09
- Revenue
- PODD $2,198,900,000.00
- NTNX $2,432,612,000.00
- Revenue This Year
- PODD $24.49
- NTNX $19.93
- Revenue Next Year
- PODD $17.45
- NTNX $15.52
- P/E Ratio
- PODD $54.39
- NTNX $804.92
- Revenue Growth
- PODD 23.48
- NTNX 16.11
- 52 Week Low
- PODD $173.00
- NTNX $43.35
- 52 Week High
- PODD $329.33
- NTNX $83.36
- Technical
- Relative Strength Index (RSI)
- PODD 47.89
- NTNX 41.68
- Support Level
- PODD $299.47
- NTNX $71.49
- Resistance Level
- PODD $310.18
- NTNX $74.84
- Average True Range (ATR)
- PODD 6.79
- NTNX 1.95
- MACD
- PODD -3.22
- NTNX -0.71
- Stochastic Oscillator
- PODD 25.26
- NTNX 16.36
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
About NTNX Nutanix Inc.
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.